MARKET

MTFB

Motif Bio
MTFB
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-2.1344
-
-3.2311
50,966,896.26
About MTFB
Motif Bio plc is a clinical-stage biopharmaceutical company. The Company is engaged in development of antibiotics, which are designed for treatment of infections caused by multi-drug resistant bacteria. It operates in the development and commercialization of pharmaceutical formulations segment. The Company is focused on development of its product, Iclaprim, for the treatment of the bacterial infections, such as acute bacterial skin and skin structure infections (ABSSSI) and hospital acquired bacterial pneumonia (HABP), including those caused by resistant strains, such as methicillin-resistant Staphylococcus aureus (MRSA) and multi-drug resistant Streptococcus pneumonia (MDRSP). Iclaprim exhibits potent activity against Gram-positive clinical isolates of various genera of staphylococci. It intends to build a portfolio of antibiotics by licensing drug candidates from organizations specializing in antibacterial research, and is pursuing programs in various stages of development.
More

MTFB News

More
UPDATE 2-Mexico's Televisa wins injunction on part of Disney-Fox deal; merger unaffected
MEXICO CITY, Dec 5- Mexican broadcaster Grupo Televisa won an injunction against Walt Disney Co's acquisition of Twenty-First Century Fox Inc's assets in Mexico, but Mexico's market regulator said on Thursday that the ruling would not stall the deal. Televisa
Reuters · 12/06/2019 03:03
UPDATE 1-Televisa wins injunction over Disney purchase of Fox assets in Mexico
MEXICO CITY, Dec 5- Mexican broadcaster Grupo Televisa has won a federal injunction against Walt Disney Co's acquisition of Twenty-First Century Fox Inc's assets in Mexico, a Televisa representative said on Thursday, a move that could at least temporarily stal
Reuters · 12/05/2019 20:32
Hedge fund titan Steve Cohen in talks to increase his stake in Mets
Hedge fund titan Steve Cohen in talks to increase stake in the New York Mets, his family office says.
CNBC.com · 12/04/2019 20:44
Mayor Pete is Hollywood's top pick now that Kamala Harris is out of the presidential race
Celebrities and entertainment executives have poured money into Pete Buttigieg's campaign, and he may be poised to benefit further after Kamala Harris dropped out.
CNBC.com · 12/04/2019 13:15
Investment guru Mellody Hobson: Financial illiteracy is 'dangerous' for society
Mellody Hobson, co-CEO and president of Ariel Investments, is a fierce advocate for financial literacy. Here's what she thinks needs to be done.
CNBC.com · 12/04/2019 13:00
The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 26)
Benzinga · 11/27/2019 12:26
The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen
Benzinga · 11/27/2019 12:26
The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug
Benzinga · 11/26/2019 13:06

Hot Stocks

Symbol
Price
%Change

Webull offers kinds of Motif Bio stock information, including NASDAQ:MTFB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MTFB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MTFB stock methods without spending real money on the virtual paper trading platform.